Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:41 PM
NCT ID:
NCT04645706
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years old
* Diagnosis of CML-PC according to the criteria of the European Leukemia Net (Baccarani et al, 2013)
* Patients treated with TKI for at least 3 years (imatinib, nilotinib, dasatinib, bosutinib, ponatinib)
* Patients meeting the criteria of the French STIM study: deep molecular response of MR4.5 type (threshold of 0.0032%) or MR5 type (threshold of 0.001%) for at least 2 years,
* Free subject, without guardianship or curatorship or subordination
* Patients benefiting from a Social Security system or benefiting from it through a third party
Exclusion Criteria:
* Refusal to participate in the research
* Patients not benefiting from a Social Security scheme or not benefiting from it through a third party
* Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection, and finally patients in emergencies
* Patient having stopped treatment for another reason than: deep molecular response of MR4.5 (threshold of 0.0032%) or MR5 (threshold of 0.001%) for at least 2 years
Translated with www.DeepL.com/Translator (free version)
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT04645706
Study Brief:
Protocol Section:
NCT04645706